Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alkaloid AD Skopje's share price for the quarter that ended in Mar. 2026 was MKD25150. Alkaloid AD Skopje's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1 Mil. Therefore, Alkaloid AD Skopje's market cap for the quarter that ended in Mar. 2026 was MKD35,436 Mil.
Alkaloid AD Skopje's quarterly market cap
declined
from Sep. 2025 (MKD36,070 Mil) to Dec. 2025 (MKD35,211 Mil) but then
increased
from Dec. 2025 (MKD35,211 Mil) to Mar. 2026 (MKD35,436 Mil).
Alkaloid AD Skopje's annual market cap
increased
from Dec. 2023 (MKD25,573 Mil) to Dec. 2024 (MKD39,804 Mil) but then
declined
from Dec. 2024 (MKD39,804 Mil) to Dec. 2025 (MKD35,211 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alkaloid AD Skopje's Enterprise Value for Today is MKD36,716 Mil.
Alkaloid AD Skopje (XMAE:ALK) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Alkaloid AD Skopje Market Cap Related Terms
Alkaloid AD Skopje Market Cap Historical Data
* Premium members only.
The historical data trend for Alkaloid AD Skopje's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAE:ALK vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkaloid AD Skopje Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Market Cap distribution charts can be found below:
* The bar in red indicates where Alkaloid AD Skopje's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Alkaloid AD Skopje's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alkaloid AD Skopje (XMAE:ALK) has a Market Cap of MKD34,093 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alkaloid AD Skopje and its competitors. According to the industry distribution chart, Alkaloid AD Skopje ranks #342 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 33.5%.
Is Alkaloid AD Skopje's Market Cap too high?
Alkaloid AD Skopje's current Market Cap is MKD34,093 Mil. Based on the distribution chart, Alkaloid AD Skopje ranks #342 out of 1020 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Alkaloid AD Skopje has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkaloid AD Skopje ranks #342 out of 1020 companies for Market Cap. This puts Alkaloid AD Skopje in the upper half of its industry. The industry median Market Cap is 206.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Alkaloid AD Skopje and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkaloid AD Skopje's current Market Cap is MKD34,093 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,200.00 — trading 10.9% below its estimated fair value. The current Market Cap is MKD34,093 Mil. Alkaloid AD Skopje's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Market Cap is MKD34,093 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?
Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued.
The current stock price of MKD24,200.00 is trading 10.9% below its estimated GF Value™ of MKD27,166.15.
GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.
Key valuation signals for XMAE:ALK:
Market Cap: MKD34,093 Mil
GF Value™: MKD27,166.15 vs. price of MKD24,200.00 (10.9% below fair value)
No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
84GF Score
Get the complete analysis for XMAE:ALK
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAE:ALK has been successfully added to your 
